Correlation Between Unicycive Therapeutics and PaxMedica, Common

Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and PaxMedica, Common at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and PaxMedica, Common into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Unicycive Therapeutics and PaxMedica, Common Stock, you can compare the effects of market volatilities on Unicycive Therapeutics and PaxMedica, Common and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of PaxMedica, Common. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and PaxMedica, Common.

Diversification Opportunities for Unicycive Therapeutics and PaxMedica, Common

-0.79

Correlation Coefficient

Unicycive Therapeutics  PaxMedica, Common

Pay attention - limited upside

The 3 months correlation between Unicycive and PaxMedica, is -0.79. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and PaxMedica, Common Stock in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PaxMedica, Common Stock and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with PaxMedica, Common. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PaxMedica, Common Stock has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and PaxMedica, Common go up and down completely randomly.

Pair Corralation between Unicycive Therapeutics and PaxMedica, Common

If you would invest  32.00  in Unicycive Therapeutics on August 31, 2024 and sell it today you would earn a total of  36.00  from holding Unicycive Therapeutics or generate 112.5% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	1.59%
Values	Daily Returns

Unicycive Therapeutics  vs.  PaxMedica, Common Stock

Unicycive Therapeutics

Risk-Adjusted Performance

19 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Unicycive Therapeutics are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady fundamental indicators, Unicycive Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

PaxMedica, Common Stock

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days PaxMedica, Common Stock has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, PaxMedica, Common is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Unicycive Therapeutics and PaxMedica, Common

The main advantage of trading using opposite Unicycive Therapeutics and PaxMedica, Common positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, PaxMedica, Common can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PaxMedica, Common will offset losses from the drop in PaxMedica, Common's long position.

The idea behind Unicycive Therapeutics and PaxMedica, Common Stock pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.